Hangzhou Jiuyuan Genetic Biopharmaceutical (HKG:2566) completed the conversion of all its 136.3 million unlisted shares into Hong Kong-listed shares on Thursday, according to a same-day bourse filing.
Shares of the firm were down over 1% in late morning trade on Friday.
The listing of and dealing in converted shares on the Hong Kong Stock Exchange began at 9:00 am on Friday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments